Invasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response to chemotherapy. Besides loss of E-cadherin, a hallmark of ILC, genetic inactivation of PTEN is frequently observed in patients. Through concomitant Cre-mediated inactivation of E-cadherin and PTEN in mammary epithelium, we generated a mouse model of classical ILC (CLC), the main histological ILC subtype. While loss of E-cadherin induced cell dissemination and apoptosis, additional PTEN inactivation promoted cell survival and rapid formation of invasive mammary tumors that recapitulate the histological and molecular features, estrogen receptor (ER) status, growth kinetics, metastatic behavior, and tumor microenvironment of human CLC. Combined inactiva...
Invasive lobular carcinoma (ILC) is the second most frequently diagnosed histologic subtype of invas...
Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC...
Although mutational inactivation of E-cadherin (CDH1) is the main driver of invasive lobular breast ...
SummaryInvasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response to...
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer. Hallmarks of ILC i...
Metastatic disease is the primary cause of death in breast cancer, the most common malignancy in Wes...
Metastatic disease is the primary cause of death in breast cancer, the most common malignancy in Wes...
Despite the fact that loss of E-cadherin is causal to the development and progression of invasive lo...
Despite the fact that loss of E-cadherin is causal to the development and progression of invasive lo...
Infiltrating lobular breast cancer (ILC) is the most common special breast cancer subtype. With muta...
SUMMARY Breast cancer is the most common malignancy in women of the Western world. Even though a lar...
Invasive lobular breast cancer (ILC) is a subtype of breast cancer accounting for 10-15% of all inva...
Invasive lobular breast cancer (ILC) is a subtype of breast cancer accounting for 10-15% of all inva...
Invasive lobular carcinoma (ILC) is the second most frequently diagnosed histologic subtype of invas...
Mouse models that faithfully recapitulate human cancers are indispensable tools for studying the mol...
Invasive lobular carcinoma (ILC) is the second most frequently diagnosed histologic subtype of invas...
Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC...
Although mutational inactivation of E-cadherin (CDH1) is the main driver of invasive lobular breast ...
SummaryInvasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response to...
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer. Hallmarks of ILC i...
Metastatic disease is the primary cause of death in breast cancer, the most common malignancy in Wes...
Metastatic disease is the primary cause of death in breast cancer, the most common malignancy in Wes...
Despite the fact that loss of E-cadherin is causal to the development and progression of invasive lo...
Despite the fact that loss of E-cadherin is causal to the development and progression of invasive lo...
Infiltrating lobular breast cancer (ILC) is the most common special breast cancer subtype. With muta...
SUMMARY Breast cancer is the most common malignancy in women of the Western world. Even though a lar...
Invasive lobular breast cancer (ILC) is a subtype of breast cancer accounting for 10-15% of all inva...
Invasive lobular breast cancer (ILC) is a subtype of breast cancer accounting for 10-15% of all inva...
Invasive lobular carcinoma (ILC) is the second most frequently diagnosed histologic subtype of invas...
Mouse models that faithfully recapitulate human cancers are indispensable tools for studying the mol...
Invasive lobular carcinoma (ILC) is the second most frequently diagnosed histologic subtype of invas...
Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC...
Although mutational inactivation of E-cadherin (CDH1) is the main driver of invasive lobular breast ...